 GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 GLOBE NEWSWIRE -- Applied Genetic Technologies Corporation Nasdaq: AGTC, a biotechnology company conducting human clinical trials of adeno-associated virus AAV-based gene therapies for the treatment of rare diseases, today announced that management will be participating in the following virtual investor conferences: 